Schedule 13G ownership disclosure

Celsus Therapeutics Plc.

Security class unavailable · CUSIP: 15119A103

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,385,000
Percent of class
9.6800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000017
Form type
SC 13G/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Jan 09, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub